Methods for prevention of acute post-endoscopic retrograde cholangiopancreatography pancreatitis

Kamil Jaszczuk; Michał Lipiński; Grażyna Rydzewska

doi:10.5114/pg.2020.95555

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2020
vol. 15

Send email

Copy url:

abstract:

Review paper

Methods for prevention of acute post-endoscopic retrograde cholangiopancreatography pancreatitis

Kamil Jaszczuk

¹

,

Michał Lipiński

¹

,

Grażyna Rydzewska

²

Department of Internal Medicine and Gastroenterology with IBD Subdivision, Central Clinical Hospital of the Ministry of the Interior, Warsaw, Poland
Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland

Gastroenterology Rev 2020; 15 (2): 98–102

DOI: https://doi.org/10.5114/pg.2020.95555

Online publish date: 2020/06/08

View full text Get citation

PlumX metrics:

Acute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP), with incidence rates ranging between 2% and 16%. In addition to being experienced in endoscopic procedures and having knowledge of the patient qualification criteria, physicians should also be aware of the patient and procedure-related risk factors responsible for post-ERCP pancreatitis (PEP). Intrarectal administration of nonsteroidal anti-inflammatory drugs and pancreatic duct stenting were demonstrated to be efficient in high-risk patients. This review provides a broader summary of pharmacological methods and techniques aimed at reducing the risk of PEP.

keywords:

post-endoscopic retrograde cholangiopancreatography pancreatitis, endoscopic retrograde cholangiopancreatography, nonsteroidal anti-inflammatory drugs, pancreatic duct stents

Methods for prevention of acute post-endoscopic retrograde cholangiopancreatography pancreatitis

Kamil Jaszczuk 1 , Michał Lipiński 1 , Grażyna Rydzewska 2

post-endoscopic retrograde cholangiopancreatography pancreatitis, endoscopic retrograde cholangiopancreatography, nonsteroidal anti-inflammatory drugs, pancreatic duct stents

Kamil Jaszczuk

¹

,

Michał Lipiński

¹

,

Grażyna Rydzewska

²